• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number BLIS-X1
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Endophthalmitis (1835); Hypopyon (1913); Intraocular Pressure Increased (1937); Visual Impairment (2138)
Date of Event 02/27/2026
Type of Reportable Event Serious Injury
Event or Problem Description
A surgeon reported that 1 day after implantation of an intraocular lens (iol) into the left eye (os) of a patient endophthalmitis occurred in the operated eye.At the one-day post op slit lamp findings the surgeon noted hypopyon, ac cells and flare, a decrease in patients bcva.Initial treatment consisted of topical moxifloxacin and prednisone acetate.Two days after the initial procedure the patient had an elevated iop of 36mmhg.Three days after the lens was initially placed a vitrectomy was performed.Culture and sensitivity performed was positive for enterococcus faecalis.Intraocular injections with an unspecified medication were administered for endophthalmitis treatment on postoperative day 5 and postoperative day 7 following the original iol placement.At the time of reporting, the patient¿s prognosis and ongoing treatment course were described as good.
 
Additional Manufacturer Narrative
The device was discarded per the reporter and therefore not available for evaluation.A review of device history record (dhr) did not find any non-conformities or anomalies related to the reported event.The lot history, trend analysis, risk analysis, and directions for use are considered acceptable with the product performing within anticipated rates.Based on the available information, the root cause of this event could not be determined.Bausch + lomb will continue to monitor for similar occurrences.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE
Common Device Name
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
Manufacturer (Section G)
MEDICEL AG
dornierstrasse 11
alternhein FL CH-94 23
SZ   CH-9423
Manufacturer Contact
shayan habibi
21 north park place blvd.
clearwater, FL 
7277246600
MDR Report Key24780426
Report Number0001313525-2026-00026
Device Sequence Number9935423
Product Code MSS
UDI-Device Identifier00757770520183
UDI-Public(01)00757770520183(17)261026(11)241028(10)2402709
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
K131958
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/03/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberBLIS-X1
Device Catalogue NumberBLIS-X1
Device Lot Number2402709
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/04/2026
Initial Report FDA Received Date04/03/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/28/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
BLIS R1 HANDPIECE AND ENVISTA INTRAOCULAR LENS.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age59 YR
Patient SexFemale
-
-